Published in Health Econ on August 01, 2005
Economic evaluation of dose-response resistance training in older women: a cost-effectiveness and cost-utility analysis. Osteoporos Int (2010) 1.05
The independent contribution of executive functions to health related quality of life in older women. BMC Geriatr (2010) 1.04
Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int (2010) 1.02
Immediate computed tomography or admission for observation after mild head injury: cost comparison in randomised controlled trial. BMJ (2006) 0.99
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. Pharmacoeconomics (2014) 0.99
Economic evaluations: a new avenue of outcome assessment in spinal disorders. Eur Spine J (2005) 0.93
Estimates of patient costs related with population morbidity: can indirect costs affect the results? Eur J Health Econ (2010) 0.93
Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res (2008) 0.92
Cost-utility analysis of a one-time supervisor telephone contact at 6-weeks post-partum to prevent extended sick leave following maternity leave in The Netherlands: results of an economic evaluation alongside a randomized controlled trial. BMC Public Health (2011) 0.91
Falls-related self-efficacy is independently associated with quality-adjusted life years in older women. Age Ageing (2011) 0.90
The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee. Ann Rheum Dis (2006) 0.90
Economic evaluation of a weight control program with e-mail and telephone counseling among overweight employees: a randomized controlled trial. Int J Behav Nutr Phys Act (2012) 0.83
The cost-effectiveness of a family meetings intervention to prevent depression and anxiety in family caregivers of patients with dementia: a randomized trial. Trials (2013) 0.77
Sustained economic benefits of resistance training in community-dwelling senior women. J Am Geriatr Soc (2011) 0.76
Cost-effectiveness of cranberries vs antibiotics to prevent urinary tract infections in premenopausal women: a randomized clinical trial. PLoS One (2014) 0.76
Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease. Eur J Health Econ (2015) 0.76
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). PLoS One (2016) 0.75
Economic evaluation alongside a single RCT of an integrative psychotherapeutic nursing home programme. BMC Health Serv Res (2013) 0.75
Mobility predicts change in older adults' health-related quality of life: evidence from a Vancouver falls prevention prospective cohort study. Health Qual Life Outcomes (2015) 0.75
Mobility Is a Key Predictor of Change in Well-Being Among Older Adults Who Experience Falls: Evidence From the Vancouver Falls Prevention Clinic Cohort. Arch Phys Med Rehabil (2015) 0.75
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study. BMC Med Res Methodol (2016) 0.75
Within-trial economic evaluation of diabetes-specific cognitive behaviour therapy in patients with type 2 diabetes and subthreshold depression. BMC Public Health (2010) 0.75
Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia. Br J Sports Med (2013) 0.75
Economic evaluation of aerobic exercise training in older adults with vascular cognitive impairment: PROMoTE trial. BMJ Open (2017) 0.75
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Dis Extra (2017) 0.75
Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology. Pharmacoeconomics (2017) 0.75
Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med (2003) 2.01
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol (2013) 1.36
Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force. Value Health (2013) 1.18
The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine (2007) 1.16
Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics (2003) 1.14
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study. Cancer (2008) 0.99
A microcosting study of intensive care unit stay in the Netherlands. J Intensive Care Med (2008) 0.94
Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty. Soc Sci Med (2003) 0.89
Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research. Value Health (2008) 0.86
Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease. Value Health (2011) 0.85
Continuous versus intermittent data collection of health care utilization. Med Decis Making (2013) 0.84
Portfolio theory and cost-effectiveness analysis: a further discussion. Value Health (2004) 0.81
Portfolio theory and the alternative decision rule of cost-effectiveness analysis: theoretical and practical considerations. Soc Sci Med (2004) 0.81
A comparative study of resource use and costs of renal, liver and heart transplantation. Transpl Int (2005) 0.80
The role of value-of-information analysis in a health care research priority setting: a theoretical case study. Med Decis Making (2012) 0.78
Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma. J Med Econ (2011) 0.77
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial. Eur Respir J (2012) 0.77
A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes. Pharmacoeconomics (2013) 0.77
The cost utility of solifenacin in the treatment of overactive bladder. Int Urol Nephrol (2008) 0.76
Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions. Vaccine (2009) 0.76
Optimising the performance of an outpatient setting. Swiss Med Wkly (2004) 0.75
A risk-adjusted approach to comparing the return on investment in health care programs. Int J Health Care Finance Econ (2004) 0.75